Drug Profile
Research programme: galanin receptor agonists - AstraZeneca
Alternative Names: Galanin-receptor-agonists-research-programme-AstraZeneca; GalnonLatest Information Update: 14 Feb 2008
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Galanin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Absence epilepsy